NCT00150319 An Open-Label Study To Assess The Pharmacokinetics, Safety And Toleration Of Vfend®; Following Multiple Dosing With Vfend Status TERMINATED Phase PHASE1/PHASE2
NCT00150293 Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures. Status COMPLETED Phase PHASE3
NCT00150267 A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension Status COMPLETED Phase PHASE3
NCT00150254 12 Week Evaluation of the Safety and Efficacy of 4 Dosing Strategies of CP-526,555 and Placebo for Smoking Cessation. Status COMPLETED Phase PHASE2
NCT00150241 A Seven-Week Dose-Ranging Study of CP-526,555 Compared With Placebo and Zyban for Smoking Cessation Status COMPLETED Phase PHASE2
NCT00150228 12 Week Evaluation of the Safety and Efficacy of a Flexible Dose of CP-526,555 and Placebo for Smoking Cessation Status COMPLETED Phase PHASE2
NCT00150215 A First In Human Study Of PF-00184562 In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00150202 Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration) Status COMPLETED Phase PHASE3
NCT00148837 Efficacy of Prazosin Versus Placebo Associated With Peg-interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis Status COMPLETED Phase PHASE2
NCT00147602 Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke Status COMPLETED Phase PHASE4
NCT00147576 Study To Examine Effect Of CP-866,087 On Consumption And Craving Of Alcohol In Alcohol Dependent Subjects. Status COMPLETED Phase PHASE2
NCT00147563 Compare Effectiveness of Eplerenone vs Atenolol in Reversing the Remodelling Resistance Arteries in Subjects With HT Status COMPLETED Phase PHASE4
NCT00147550 MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma. Status TERMINATED Phase PHASE1/PHASE2
NCT00147537 Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00147524 Non-Comparative Study To Evaluate Changes In FMD After Quinapril Therapy In Hypertensive Women Status COMPLETED Phase PHASE4
NCT00147498 Three Dose Levels of CP-690,550 Monotherapy Versus Placebo, Administered Orally Twice Daily (BID) for 6 Weeks Status COMPLETED Phase PHASE2
NCT00147485 A Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced Cancer Status TERMINATED Phase PHASE1
NCT00145431 Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder. Status TERMINATED Phase PHASE3